HRT Financial’s Turnstone Biologics TSBX Stock Holding History

HRT Financial’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-55,859	Closed	-$20K	–	3689
2025 Q2	$20K	Buy	55,859 +43,776	+362%	+$15.3K	﹤0.01%	2402
2025 Q1	$4K	Buy	+12,083	New	+$5.14K	﹤0.01%	2415

HRT Financial's TSBX Position: Q3 2025 in Review

HRT Financial sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 55,859 shares — an estimated $20K sold.

HRT Financial first reported a position in TSBX in Q1 2025 and held it in 2 quarters. The position peaked at $20K in Q2 2025. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

HRT Financial reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
HRT Financial sold 55,859 Turnstone Biologics shares in Q3 2025, an estimated $20K.
HRT Financial first reported a position in Turnstone Biologics in Q1 2025 and held it in 2 quarters.
HRT Financial's Turnstone Biologics position peaked at $20K in Q2 2025.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.